Refeyn
Developer of a technology for the measurement of single molecular mass
📍 Oxford, United Kingdom · Life Sciences Platforms and Tools
Funding snapshot
Last roundSeries B
Amount$33M
Date5 April 2022
About
Refeyn develops technology for the measurement of single molecular mass. The company's product includes Refyn (mass photometry) that uses single-molecule light scattering for the detection of molecular properties of biomolecules.
Latest news
No articles yet.